Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
VSee Health ( (VSEE) ) has issued an update.
On October 21, 2025, VSee Health, Inc. amended its senior secured convertible promissory note, originally issued on September 30, 2024, to redefine the ‘Conversion Price’ to $0.75. This amendment maintains all other terms of the note, potentially impacting the company’s financial strategy and investor relations.
The most recent analyst rating on (VSEE) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.
VSee Health’s overall stock score is heavily impacted by financial instability and the risk of Nasdaq delisting. While there is some revenue growth, the negative equity, poor valuation, and bearish technical indicators contribute to a low score.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
Average Trading Volume: 5,085,551
Technical Sentiment Signal: Sell
Current Market Cap: $8.31M
See more data about VSEE stock on TipRanks’ Stock Analysis page.